Lassa fever resources
PPE washing and drying station Lassa ward Owo
ISARIC is committed to strengthening the evidence base for Lassa fever therapeutics and improving case management. We have initiated a number of activities to address these knowledge gaps, which are conducted alongside a wide-range of partners and collaborators.
Introduction to Lassa Fever
Tile subhead - What is Lassa fever? Context and treatments.
Lassa fever: addressing knowledge gaps
Tile subhead - How can case management and treatment outcomes be improved?
Ribavirin and supportive care
Tile subhead - Analyses of current treatments for Lassa.
West Africa Lassa fever Consortium (WALC)
Tile subhead - Explore WALC's framework for Lassa fever treatment.
Publication library
Visit this section to find ISARIC’s articles, studies and more.
Latest news
Researchers from Madagascar, Oxford successfully enrol over 220 cases for landmark plague trial
IMASOY, a randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague, has enrolled over 220 cases of confirmed or probable bubonic plague in Madagascar, marking a critical milestone in plague treatment research.
Children hospitalised with Omicron did not have a higher risk of experiencing long-term health issues compared to other infections, finds latest study
8 February 2024: A new study finds that children hospitalised with initial COVID-19 variant showed more signs of dermatological, fatigue, gastrointestinal, sensory, and sleep issues, as well as behavioural and emotional problems.
Public health vision led by ISARIC partners aims to tackle Nipah virus
15 January 2024: In a new paper published in The Lancet Infectious Diseases, researchers based in Bangladesh, Oxford and Geneva call for a comprehensive public health framework to counter Nipah virus and other neglected infectious diseases with pandemic potential.